These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7026259)

  • 1. Comparative study of the effect of azepexole and clonidine on blood pressure and pulse rate in normotensive subjects.
    Benedikter L; Mey T; Middleton DA
    Eur J Clin Pharmacol; 1981; 20(5):321-8. PubMed ID: 7026259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of azepexole and clonidine on baroreceptor mediated reflex bradycardia and physiological tremor in man.
    Harron DW; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1985 Nov; 20(5):431-6. PubMed ID: 2866788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of azepexole on blood pressure, pulse rate, plasma renin activity and urinary catecholamines in normotensive subjects.
    McKenna F; Davison AM
    Curr Med Res Opin; 1983; 8(6):405-11. PubMed ID: 6342954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of guanabenz and clonidine in hypertensive patients.
    Kluyskens Y; Snoeck J
    Curr Med Res Opin; 1980; 6(9):638-43. PubMed ID: 6996935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter double-blind comparative study of rilmenidine and clonidine in 333 hypertensive patients.
    Fillastre JP; Letac B; Galinier F; Le Bihan G; Schwartz J
    Am J Cardiol; 1988 Feb; 61(7):81D-85D. PubMed ID: 2894165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The central hypotensive effect of clonidine. Studies in tetraplegic subjects.
    Reid JL; Wing LM; Mathias CJ; Frankel HL; Neill E
    Clin Pharmacol Ther; 1977 Apr; 21(4):375-81. PubMed ID: 321174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary clinical pharmacological studies of S3341, a new hypotensive agent, and comparison with clonidine in normal males.
    Weerasuriya K; Shaw E; Turner P
    Eur J Clin Pharmacol; 1984; 27(3):281-6. PubMed ID: 6150856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind comparison of the hypotensive, sedative and salivary flow effects of lofexidine and clonidine in normal subjects.
    Dollery CT; Reid JL
    Arzneimittelforschung; 1982; 32(8a):984-7. PubMed ID: 6890374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative trial of clonidine, propranolol and placebo in the treatment of moderate hypertension.
    Wilkinson PR; Raftery EB
    Br J Clin Pharmacol; 1977 Jun; 4(3):289-94. PubMed ID: 332218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the haemodynamic and behavioural effects of moxonidine and clonidine in normotensive subjects.
    Macphee GJ; Howie CA; Elliott HL; Reid JL
    Br J Clin Pharmacol; 1992 Mar; 33(3):261-7. PubMed ID: 1576046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the efficacy and safety of guanabenz versus clonidine.
    Leary WP; Asmal AC; Williams PC
    S Afr Med J; 1979 Jan; 55(3):83-5. PubMed ID: 371036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of rilmenidine and clonidine on the electroencephalogram, saccadic eye movements, and psychomotor function.
    Harron DW; Hasson B; Regan M; McClelland RJ; King DJ
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S48-54. PubMed ID: 8642806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An alternative method of assessing changes in salivary flow: comparison of the effects of clonidine and tiamenidine (HOE 440).
    Findlay D; Lawrence JR
    Eur J Clin Pharmacol; 1978 Dec; 14(4):231-5. PubMed ID: 729618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central effects of guanfacine and clonidine during wakefulness and sleep in healthy subjects.
    Spiegel R; DeVos JE
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):165S-168S. PubMed ID: 6994771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naloxone does not antagonize the antihypertensive effect of clonidine in essential hypertension.
    Rogers JF; Cubeddu LX
    Clin Pharmacol Ther; 1983 Jul; 34(1):68-73. PubMed ID: 6305546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alinidine, a novel bradycardic agent, on heart rate and blood pressure in man.
    Harron DW; Jady K; Riddell JG; Shanks RG
    J Cardiovasc Pharmacol; 1982; 4(2):213-20. PubMed ID: 6175803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selectivity of rilmenidine for the nucleus reticularis lateralis, a ventrolateral medullary structure containing imidazoline-preferring receptors.
    Tibiriça E; Feldman J; Mermet C; Monassier L; Gonon F; Bousquet P
    Eur J Pharmacol; 1991 Dec; 209(3):213-21. PubMed ID: 1686768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of the alpha 2-adrenoceptor agonist rilmenidine.
    Van Zwieten PA
    Am J Cardiol; 1988 Feb; 61(7):6D-14D. PubMed ID: 2894160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive effects of urapidil and clonidine: a double-blind cross-over study.
    Kanniainen E; Heikkilä O; Jääskeläinen T; Lilja M; Jounela AJ
    Eur J Clin Pharmacol; 1985; 28(1):35-9. PubMed ID: 3886400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of clonidine on cardiovascular responses to standing in healthy volunteers.
    Coupland NJ; Bailey JE; Wilson SJ; Horvath R; Nutt D
    Clin Auton Res; 1995 Jun; 5(3):171-7. PubMed ID: 7549420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.